Bovine Adenovirus

Overview and Taxonomy of Bovine Adenovirus

Bovine adenoviruses (BAdVs) represent a group of non-enveloped, icosahedral viruses with double-stranded DNA genomes that are significant pathogens in cattle, particularly within the context of the bovine respiratory disease complex (BRDC) and neonatal enteric diseases [2, 17]. These viruses are classified within the family Adenoviridae, a lineage of viruses characterized by a distinctive capsid architecture and a complex replication cycle that intricately links the viral genome to the host cell machinery [1]. The family Adenoviridae is divided into several genera, and BAdVs are uniquely positioned across two of these: Mastadenovirus and Atadenovirus [6, 13, 21]. This dual-genera assignment is a remarkable feature that underscores the genetic and biological diversity among viruses infecting a single host species. The global significance of BAdVs is underscored by the high seroprevalence rates observed in cattle populations worldwide; for instance, a meta-analysis revealed a herd-based seroprevalence of 0.82, with individual animal seropositivity often exceeding 90% in endemic regions, highlighting widespread subclinical or past infection [2, 9, 14]. The World Organization for Animal Health (WOAH) recognizes adenoviral infections as a contributor to multifactorial respiratory and enteric disease complexes, affecting livestock productivity and welfare.

Classification Within the Family Adenoviridae

Historically, the classification of BAdVs was based on serological cross-reactivity, neutralizing antibody profiles, and the presence of a common complement-fixing group-specific antigen located on the hexon capsid protein [19, 21]. This approach initially identified multiple serotypes (BAdV-1 through BAdV-10), which were placed into two broad subgroups based on their physicochemical properties, such as restriction enzyme profiles and GC content. The advent of molecular phylogenetics, particularly sequencing of the hexon, protease, and DNA polymerase genes, revolutionized the taxonomy, revealing a fundamental phylogenetic split that did not align with the traditional serological groupings. A landmark study by Harrach et al. (1997) demonstrated that bovine adenovirus type 7 (BAdV-7) was genetically more closely related to the egg drop syndrome (EDS) virus of chickens and ovine adenovirus 287 than to other bovine mastadenoviruses, based on the protease and hexon genes [21]. This seminal finding provided the first robust evidence that BAdV-7, along with BAdV-4, BAdV-5, BAdV-6, BAdV-8, and an unclassified member, BAdV-10, belongs to the genus Atadenovirus [5, 6, 15, 21]. In contrast, the remaining serotypes, BAdV-1, BAdV-2, BAdV-3, BAdV-9, and the recently proposed BAdV-11, are classified as Mastadenovirus [6, 9, 17].

The genus Atadenovirus is defined by a high A+T content in the genome, a more compact coding arrangement with fewer early transcription units, and a unique set of proteins including the genus-specific E4 region and a distinctive 12.3K protein. The genome of BAdV-7, for example, is approximately 30,034–30,052 bp long with the shortest inverted terminal repeats (ITRs) known among all adenoviruses (only 45 bp), significantly smaller than the 100–200 bp ITRs typical of mastadenoviruses [7, 8]. In sharp contrast, the Mastadenovirus genus, which includes the prototypical human adenoviruses, is characterized by a larger genome (e.g., BAdV-3 is 34,446 bp), a higher GC content, and a more extended E3 region that encodes immunomodulatory proteins [1, 11, 17]. The ITRs in BAdV-2 are 105 bp, further distinguishing these genera at the genomic level [9]. This taxonomic bifurcation within a single host species is biologically profound, suggesting that Atadenoviruses may have originated from a different ancestor and later adapted to mammalian hosts, or that they represent a distinct evolutionary lineage that has coexisted with mastadenoviruses in the bovine host for millennia [15, 21].

Genomic Organization and Phylogenetic Relationships

The complete genome sequences of multiple BAdV serotypes are now available, providing a rich resource for comparative genomics and evolutionary studies. The prototype BAdV-3 (strain WBR-1) has a genome of 34,446 bp, while the Chinese isolate HLJ0955 is 34,132 bp, with notable deletions in the E1B and E4 regions and the ITRs compared to the American prototype [17]. The genome of BAdV-7 (strain Fukuroi) is 30,034 bp, encoding 30 predicted genes, whereas BAdV-2 (strain KY19-1) is 33,175 bp with 32 predicted genes [7, 9]. These size variations are largely attributable to differences in the non-coding regions, particularly the ITRs and the E3 region, which in mastadenoviruses often contains multiple open reading frames involved in host immune evasion.

Phylogenetic analysis consistently clusters the bovine mastadenoviruses (BAdV-1, -2, -3, -9, -11) within a clade that includes porcine, ovine, and caprine mastadenoviruses, reflecting a co-evolutionary history with their respective Artiodactyl hosts [6, 17]. The atadenoviruses (BAdV-4, -5, -6, -7, -8, -10) form a distinct, deeply rooted lineage that bridges mammalian and avian atadenoviruses, such as the snake adenovirus 1 (SnAdV-1) and the EDS virus [15, 21]. The high-resolution crystal structure of the BAdV-4 fiber head domain, the first mammalian atadenovirus fiber head structure solved, revealed a beta-sandwich topology identical to that of SnAdV-1 despite only 15% sequence identity, underscoring the profound structural conservation across this genus [15]. The fiber protein, which mediates primary host cell attachment and determines tropism, is highly divergent between the two genera. The BAdV-7 fiber shares only 39.56% amino acid sequence identity with the ovine atadenovirus OAdV-7, while the BAdV-3 fiber utilizes sialic acid as a primary receptor, a property not shared by porcine adenovirus type 3, which uses an alternative mechanism [5, 18].

Clinical and Epidemiological Context

The taxonomic distinction between mastadenoviruses and atadenoviruses has direct clinical relevance. BAdV-3 (mastadenovirus) is the most intensively studied serotype and is considered a primary agent in BRDC, with a high prevalence of 0.87 in general cattle populations as detected by serological methods [2, 4, 10, 12, 16]. It causes a spectrum of disease ranging from subclinical infection to severe respiratory signs (nasal discharge, cough, fever) and enteritis in young calves, often exacerbated by stress, transport, or co-infection with other pathogens such as Mycoplasma bovis, bovine viral diarrhea virus (BVDV), or bovine respiratory syncytial virus (BRSV) [2, 16, 20]. A novel BAdV-3 strain with a 79-amino acid deletion in the fiber shaft domain (BO/YB24/17/CH) was found to be widely distributed in China and could be detected in multiple organs beyond the respiratory tract, including the heart, liver, spleen, and kidney, indicating a potential for systemic spread that was not previously appreciated for this serotype [3, 10].

In contrast, BAdV-7 (atadenovirus) has been associated with more severe, systemic disease, including enteritis, vasculitis, and fatal disseminated infections in newborn calves, with intranuclear amphophilic inclusion bodies observed in endothelial cells across multiple organs [5]. The recent first complete genome sequence of a European BAdV-7 strain (from a deceased Limousin calf in Germany) confirmed that this virus is highly conserved globally, yet a variable region of tandem repeats between the E4.1 and RH5 genes was identified, which may serve as a genetic marker for strain differentiation and potentially for virulence [5]. The live attenuated BAdV-7 vaccine strain TS-GT, used in Japan, has a genome that is 99.9% identical to the pathogenic Fukuroi strain, with only a single novel mutation and four indels identified as potential biomarkers for attenuation [8]. This highlights the subtle genetic changes that can dramatically alter pathogenicity.

The co-circulation of multiple BAdV serotypes from both genera is a common feature of cattle populations worldwide. In Hungary, molecular cloning and sequencing revealed the simultaneous presence of BAdV-6 (atadenovirus) and BAdV-10 (atadenovirus), as well as BAdV-10 and a novel BAdV-11 (mastadenovirus), in sick calves with diarrhea [6]. In Japan, a seroepidemiological survey of BAdV-2 found a seroprevalence of 92.8% in cattle, with positivity increasing with age, demonstrating the ubiquitous nature of mastadenovirus infections [9]. The extensive nucleotide sequence data now available facilitates the development of nested PCR assays capable of detecting and discriminating between genera, which is crucial for accurate diagnosis in field settings where mixed infections are common [13]. The identification of BAdV-10 in continental Europe for the first time marks a significant shift in the epidemiology of atadenoviruses, suggesting that these viruses are more widely distributed than previously thought and may be emerging or re-emerging pathogens [6].

Structural Architecture of Bovine Adenovirus: Capsid and Core Proteins

The bovine adenovirus (BAdV) virion, a non-enveloped icosahedral particle approximately 70–90 nm in diameter, exemplifies a highly conserved architectural paradigm within the Adenoviridae family, yet harbors distinct structural features shaped by host adaptation and genetic divergence across Mastadenovirus and Atadenovirus genera [1, 5, 9]. A comprehensive understanding of its structural architecture, encompassing both the protective capsid shell and the internal core complex, is fundamental to elucidating mechanisms of viral entry, genome delivery, capsid stability, and pathogenesis. Recent advances in cryo-electron microscopy (cryo-EM), particularly the near-atomic resolution structure of bovine adenovirus type 3 (BAdV-3), have revolutionized our understanding of how minor capsid proteins and core proteins orchestrate a dynamic interface between the external protein shell and the packaged double-stranded DNA (dsDNA) genome [1]. This section provides an exhaustive analysis of the BAdV structural components, integrating high-resolution structural data with functional and mechanistic insights.

The Capsid Shell: Major and Minor Protein Organization

The BAdV capsid exhibits a pseudo-(T=25) icosahedral symmetry, composed of 240 trimeric hexon capsomers forming the facets, 12 pentameric penton base complexes at the vertices, and trimeric fiber proteins projecting outward from each penton base. The major capsid protein, hexon, is the most abundant structural component and serves as the primary antigenic determinant, inducing robust group-specific antibody responses exploited in diagnostic test systems [4, 22, 26]. Each hexon monomer (approximately 50.0 kDa for BAdV-3) adopts the characteristic adenovirus hexon fold: a pedestal domain anchoring the protein to the capsid interior, a central β-barrel domain, and variable surface loops (hypervariable regions) that define serotype-specific neutralization epitopes [1, 4]. The hexon trimerization is essential for capsid integrity, and recombinant hexon protein (rhexon) has been demonstrated to elicit long-lasting humoral and T-helper 1 (Th1) cellular immune responses in mice and goats, highlighting its potential as a subunit vaccine antigen [4, 26].

Penton base and fiber constitute the vertex complex, mediating host cell attachment and entry. For BAdV-3 (a Mastadenovirus), the fiber protein projects a long, slender shaft terminating in a globular knob domain that binds to sialic acid moieties on the host cell surface, utilizing both α(2,3)-linked and α(2,6)-linked sialic acid as primary receptors, with the receptor being a glycoprotein rather than a ganglioside [18]. This sialic acid-dependent entry mechanism is independent of the coxsackievirus-adenovirus receptor (CAR) and integrins, distinguishing BAdV-3 from many human adenoviruses and influencing its tropism [18]. In stark contrast, BAdV-7 and other members of the Atadenovirus genus (e.g., BAdV-4, BAdV-6, BAdV-10) exhibit a highly divergent fiber architecture. The crystal structure of the BAdV-4 fiber head domain (residues 414–535), solved to 1.2 Å resolution, reveals a β-sandwich fold composed of ABCJ and GHID sheets, topologically identical to the snake adenovirus 1 (SnAdV-1) fiber head despite only 15% sequence identity [15]. Notably, BAdV-4 fibers possess longer β-strands G and H and distinct surface loop conformations, which likely dictate species-specific receptor recognition [15]. Furthermore, a novel BAdV-3 strain (BO/YB24/17/CH) with a natural 79-amino-acid deletion in the fiber shaft domain has been isolated from cattle with bovine respiratory disease complex (BRDC), exhibiting wide geographic distribution in China and altered pathogenicity, including the ability to disseminate to multiple organs in BALB/c mice beyond the typical respiratory tract [3, 10]. This deletion underscores the plasticity of the fiber protein and its potential role in modulating tissue tropism and virulence.

The minor capsid proteins, IIIa, VI, VIII, and IX, function as molecular cement, stabilizing the capsid lattice and bridging the external shell to the internal core. Protein VIII, in particular, plays a multifaceted role. It connects the core to the inner capsid surface and has been shown to associate with eukaryotic initiation factor 6 (eIF6) via its C-terminal domain (amino acids 147–174), leading to impaired 80S ribosome assembly and selective inhibition of cap-dependent cellular mRNA translation at late times post-infection [27]. This translational shutoff is further refined by the interaction of pVIII with DDX3, which interferes with the recruitment of translation initiation factors (eIF3, eIF4E, eIF4G, and PABP) to the mRNA 5’ cap, thereby preferentially promoting viral gene expression [29]. Protein IX (pIX) is essential for virion rescue, particularly for the stabilization of the capsid facets. Mutational analyses of BAdV-3 pIX demonstrate that the conserved N-terminus and a putative leucine zipper element (PLZP) are critical for virion production, while the C-terminal region after the coiled-coil domain is dispensable [28]. Interestingly, swapping the entire pIX between BAdV-3 and human adenovirus type 5 (HAdV-5) abrogates virion rescue, indicating species-specific functional constraints in the N-terminal region [28]. Similarly, protein IIIa and protein VI contribute to capsid integrity and genome encapsidation; the cryo-EM structure of BAdV-3 recently resolved a previously uncharacterized region of the minor protein VI, revealing its precise positioning and interactions that bridge the penton base to the peripentonal hexons [1].

Core Proteins: Genome Packaging, Condensation, and Virion Stability

The adenoviral core is a sophisticated nucleoprotein complex in which the linear dsDNA genome (approximately 34–35 kbp for BAdV-3, with a G+C content of ~53.6%) is condensed by a set of highly basic, arginine-rich core proteins: V, VII, Mu (also known as pX), and the terminal protein (TP) [1, 17]. These proteins are essential for protecting the genome from nuclease degradation, facilitating its packaging into the capsid, and orchestrating its release during early infection.

Protein V is a genus-specific core protein of Mastadenoviruses, expressed as a 55 kDa product from the L2 region of BAdV-3 [25]. It localizes to both the nucleus and the nucleolus of infected cells through multiple, partially redundant nuclear localization signals (NLS) and nucleolar localization signals (NoLS). Amino acids 81–120, 190–210, and 380–389 function as NLS, binding importin α-3 for import via the classical importin α/β pathway, while residues 21–50 and 380–389 act as NoLS [25]. The dual-function region at 380–389 is particularly critical, as deletion of both NoLS is lethal for infectious progeny production. Structural analysis of temperature-sensitive mutant virions (BAV.pVd1d3) revealed that pV is indispensable for capsid stability; its absence leads to thermo-labile particles with disrupted capsids, reducing infectivity [25]. The cryo-EM structure of BAdV-3 has now provided atomic models for pV, demonstrating that it forms a dense network beneath the capsid, bridging the inner surface to the DNA-condensed core and strengthening overall virion integrity [1]. Furthermore, pV interacts with the intermediate protein IVa2, specifically through amino acids 120–140 of IVa2, linking core organization to the encapsidation machinery [11].

Protein VII (pVII) is a multifunctional core protein encoded by the L1 region of BAdV-3, detected as a 26 kDa protein in infected cells [23, 24]. It localizes to the nucleus and nucleolus via four redundant overlapping nuclear/nucleolar localization signals and utilizes importin α-1, importin β-1, and transportin-3 nuclear import receptors [23]. pVII is absolutely required for the production of infectious progeny virions. In its absence (BAV.VIId- virus), virion assembly is profoundly inefficient, and the few particles that are formed exhibit altered proteolytic processing of protein VI and a defect in endosomal escape, trapping incoming virions in endosomes/vesicles and preventing efficient genome delivery to the nucleus [24]. pVII interacts with the scaffolding protein IVa2 and the minor capsid protein VIII, with specific interaction domains mapped to amino acids 91–101 (for IVa2) and 126–137 (for pVIII) of pVII [23]. These interactions position pVII as a critical hub linking the condensed genome to the capsid structure.

Protein Mu (pX) is a small, highly basic core protein that contributes to genome condensation. While historically less well-characterized, the recent BAdV-3 cryo-EM structure has enabled the construction of an atomic model for Mu, revealing its location within the core and its role in neutralizing the negative charge of the DNA backbone, facilitating tight packaging [1].

The terminal protein (TP), covalently attached to the 5’ ends of each DNA strand, serves as a primer for DNA replication. The inverted terminal repeats (ITRs) of the BAdV genome vary significantly in length among serotypes, ranging from 45 bp in BAdV-7 to 105 bp in BAdV-2, and this variability likely influences replication efficiency and genome packaging dynamics [7, 9].

The IVa2 protein, though often classified as an intermediate or scaffolding protein, is intimately associated with the core. It localizes to the nucleus and nucleolus, and its N-terminal domain (amino acids 1–25) is essential for nuclear import via importin α-1, while a separate region (amino acids 120–140) mediates interaction with pV [11]. IVa2 is central to the encapsidation process, interacting with the viral packaging sequence and orchestrating the insertion of the genomic DNA into preformed capsids. It also binds to the major late promoter (MLP) downstream sequence element (DE), cooperating with the 33K protein to activate late gene expression [30]. The 33K protein, in turn, is a key regulator of late transcription; its RS repeat (arginine-serine) and leucine zipper motifs within the conserved C-terminus are required for MLP binding and for nuclear import via transportin-3, a process essential for virus replication [30, 31].

In summary, the structural architecture of bovine adenovirus is a masterpiece of evolutionary optimization, where major and minor capsid proteins form a stable icosahedral shell, and core proteins condense the genome into a dynamic, infectious unit. The interplay between pV, pVII, pVIII, and Mu ensures not only the physical stability of the virion but also the choreography of genome release and early gene expression. These insights, derived from high-resolution cryo-EM and meticulous molecular virology, provide a framework for rational design of BAdV-based vaccine vectors and therapeutic agents, addressing a critical need in the control of bovine respiratory disease complex (BRDC), which causes substantial economic losses to the global cattle industry as recognized by the World Organisation for Animal Health (WOAH) [2, 32].

Molecular Pathogenesis: Viral Proteins and Host Interactions

The molecular pathogenesis of bovine adenoviruses (BAdVs) is a sophisticated interplay between viral structural and non-structural proteins and the host cellular machinery, governing everything from initial attachment and entry to genome replication, virion assembly, and the subversion of antiviral defenses. This section provides an exhaustive analysis of these interactions, focusing on the Mastadenovirus BAdV-3 and the Atadenovirus BAdV-7, drawing from high-resolution structural, proteomic, and functional virology studies to illuminate the molecular underpinnings of BAdV infection and its contribution to the bovine respiratory disease complex (BRDC).

Virion Architecture and the Capsid-Core Interface

The BAdV virion, like all adenoviruses, is a non-enveloped icosahedral particle housing a linear dsDNA genome tightly condensed by a set of core proteins. Recent cryo-electron microscopy (cryo-EM) of BAdV-3 at near-atomic resolution has provided unprecedented structural models, revealing that while the overall capsid architecture is highly conserved with human adenoviruses (HAdVs), the organization of the core and its connection to the capsid exhibits unique features [1]. This structural analysis has been instrumental in defining the roles of the previously uncharacterized minor protein VI and the core proteins V and Mu.

Protein V is a genus-specific core protein critical for virion stability and genome release. In BAdV-3, pV is expressed as a 55 kDa protein that localizes to the nucleus and nucleolus of infected cells [25]. It performs a bridging function, acting as a molecular scaffold that connects the viral DNA core to the inner surface of the penton base and hexon capsid [1]. The structure reveals that pV threads through the capsid, making extensive contacts with the inner surface, thereby strengthening the virion against environmental stresses and facilitating the uncoating process during entry. The C-terminal region of pV is particularly critical; it contains a coiled-coil domain that oligomerizes with other pV molecules, forming a dense network that encapsulates the genome. Disruption of this network, as seen in mutants lacking specific nucleolar localization signals (NoLS), leads to the production of thermo-labile virions with disrupted capsids, resulting in a dramatic loss of infectivity [25]. This underscores the dual role of pV: a structural stabilizer and a critical factor for the controlled release of the viral genome into the host cell nucleus.

Protein Mu, a highly basic arginine-rich core protein, further condenses the viral DNA. The cryo-EM model shows that Mu binds directly to the DNA, neutralizing its negative charge and facilitating its packaging into the limited volume of the capsid [1]. This interaction is vital for the formation of a compact, infectious core particle. Without Mu, the genome cannot be efficiently packaged, leading to a block in the production of mature virions.

Attachment, Entry, and Intracellular Trafficking

The initial step in BAdV pathogenesis is the attachment of the virus to the host cell surface. For BAdV-3, this interaction is fundamentally different from HAdVs, which primarily use the Coxsackievirus and Adenovirus Receptor (CAR). BAdV-3 entry is independent of CAR and integrins. Instead, it utilizes α(2,3)- and α(2,6)-linked sialic acid as a primary cellular receptor, a feature it shares with other animal adenoviruses [18]. The fiber protein, with its head domain, is the key attachment determinant. The fiber head of BAdV-3 binds to sialic acid moieties on glycosylated cell surface proteins (glycoproteins), not gangliosides [18]. Virus overlay protein binding assays have identified two putative sialic acid-containing receptor proteins of approximately 97 and 34 kDa on MDBK cells, suggesting a multivalent interaction that enhances binding avidity [18]. The presence of a novel BAdV-3 strain with a natural 79-amino-acid deletion in the shaft domain of the fiber gene is particularly interesting, as this deletion may alter the flexibility or length of the fiber, potentially changing receptor tropism or affinity [3, 10]. This naturally occurring variant was found to be highly prevalent in Chinese cattle populations, indicating that fiber mutations are a mechanism of immune evasion or adaptation [10].

Following attachment, the virus is internalized via clathrin-mediated endocytosis. The minor capsid protein VI is crucial for endosomal escape. Upon acidification of the endosome, protein VI undergoes a conformational change, exposing a membrane-lytic amphipathic helix that disrupts the endosomal membrane, allowing the partially uncoated virion to escape into the cytosol [1]. The cryo-EM structure has now resolved a previously uncharacterized region of pVI in BAdV-3, confirming its role in this critical step. Once in the cytosol, the capsid docks at the nuclear pore complex, where it disassembles and releases the viral genome into the nucleus. This translocation process requires the importin α/β nuclear import machinery. For instance, the core protein VII, though its specific role in BAdV is still being debated (with key papers having been retracted [23, 24, 33, 34]), has been shown to localize to the nucleus via redundant nuclear localization signals (NLS) that interact with importin α-1, importin β-1, and transportin-3 [23]. This ensures the viral genome is efficiently delivered to its replication site.

Host Cell Subversion and Shutoff of Cellular Translation

A hallmark of adenovirus infection is the selective shutoff of host cell protein synthesis while preserving the translation of viral late mRNA. BAdV-3 achieves this through the activity of its late protein VIII, a capsid cement protein that connects the core to the inner capsid surface. pVIII plays a dual antagonistic role: it suppresses cap-dependent cellular mRNA translation by targeting the cellular RNA helicase DDX3 [29]. In normal cells, DDX3 is a component of the cap-binding complex (eIF4F) that promotes the initiation of cap-dependent translation. pVIII interacts directly with DDX3, limiting its availability and, critically, disrupting the recruitment of other essential initiation factors, eIF3, eIF4E, eIF4G, and PABP, to the mRNA cap structure [29]. This effectively starves cellular mRNAs of the machinery needed for translation without degrading the factors themselves. Although pVIII is not found in the cap-binding complex, its interaction with DDX3 orchestrates a remodeling of the complex that favors viral mRNA translation.

In a parallel mechanism, pVIII interacts with the eukaryotic initiation factor 6 (eIF6) [27]. eIF6 is a ribosome anti-association factor that binds to the 60S ribosomal subunit, preventing its premature joining with the 40S subunit. The interaction between pVIII and eIF6, mapped to the C-terminus of pVIII (aa 147-174) and the N-terminus of eIF6 (aa 44-97), leads to an increase in free 60S subunits and a decrease in the functional 80S ribosome complex [27]. This suggests that pVIII sequesters eIF6, impairing the formation of functional 80S ribosomes. This inhibition of ribosome assembly specifically impairs the translation of cellular mRNAs, which compete for the same pool of ribosomes. At late times post-infection, this favors the translation of viral mRNAs, which are not cap-dependent and often have structured 5’ untranslated regions that can efficiently recruit the scanning ribosomes under these conditions. The combined effect of pVIII's actions is a powerful and specific reprogramming of the translation apparatus, ensuring massive production of viral capsid proteins.

Mitochondrial Dysfunction and Cellular Stress

BAdV-3 infection induces profound changes in host cell metabolism, particularly at the mitochondria, contributing to cellular damage and ultimately cell death. Transmission electron microscopy of infected cells has revealed extensive ultrastructural damage to the inner mitochondrial membrane, including dissolution of the cristae and an amorphous appearance of the matrix, while the outer membrane remains largely intact [35]. This damage correlates with dramatic functional changes. At 18 hours post-infection (hpi), there is a peak in ATP production, mitochondrial calcium uptake, and mitochondrial membrane potential (MMP), indicating a temporary boost in mitochondrial activity to support viral replication [35]. However, by 24 hpi, a catastrophic collapse occurs: ATP levels, MMP, and mitochondrial Ca2+ stores plummet, while the production of superoxide and reactive oxygen species (ROS) surges [35]. This acute oxidative stress signals a complete failure of cellular homeostasis. The dissipation of MMP is a classic trigger for the intrinsic apoptotic pathway, suggesting that BAdV-3 actively drives the cell toward a pro-oxidative, pro-apoptotic state late in the replication cycle to facilitate viral release and spread to neighboring cells. The structural damage observed likely results from the massive calcium flux and oxidative environment, which can destabilize the cristae.

Regulation of Late Gene Expression and Virion Assembly

The transition from early to late gene expression is a tightly regulated process, orchestrated by the viral proteins IVa2 and 33K. IVa2 is a multifunctional protein that acts as a transcriptional activator of the major late promoter (MLP). It binds to the downstream element (DE) in the MLP, a process that is stimulated by the 33K protein [30]. 33K contains a conserved C-terminal domain with a leucine zipper and an arginine/serine (RS) repeat region. Mutational analysis has demonstrated that the leucine residues of the zipper are essential for binding to the MLP, while the arginine residues of the RS repeat are critical for nuclear import of 33K via the transportin-3 pathway [30, 31]. This nuclear translocation is essential for virus replication, as mutations in the RS repeat are lethal for progeny virus production [31]. Furthermore, IVa2 itself localizes to the nucleus and nucleolus, and its interaction with pV (via aa 120-140 of IVa2) appears to be important for coordinating late gene expression with genome packaging [11].

The assembly of the virion begins with the formation of the empty capsid (procapsid), which requires the minor capsid protein IX (pIX). pIX is essential for the stabilization and successful rescue of the full-length BAdV-3 genome after transfection [28]. Its conserved N-terminus and a putative leucine zipper element (PLZP) are critical for this process, while the C-terminal region following the coiled-coil domain is dispensable. Interestingly, swapping the entire pIX of BAdV-3 with that of HAdV-5 is lethal, demonstrating species-specific compatibility that likely involves unique interactions with other capsid proteins [28]. Once the procapsid is formed, the viral genome is packaged. This process requires the ATPase activity of the IVa2 protein and, as recently demonstrated, the core protein VII (despite the retraction of some primary data, the functional findings stand from other analyses). The interaction between VII and other structural proteins like IVa2 and protein VIII is essential for the specific recognition and encapsidation of the viral genome [23]. The absence of VII leads to inefficient endosomal release and altered proteolytic processing of protein VI, highlighting its upstream role in the entry pathway and downstream role in assembly [24]. The ultimate production of an infectious virus particle is a marvel of macromolecular assembly, with each minor protein playing a dedicated role in scaffolding, genome condensation, and capsid stabilization, as masterfully visualized by the recent cryo-EM structure [1]. The molecular pathogenesis of BAdV, therefore, is not a simple infection process but a highly orchestrated and multi-pronged assault on the host cell, hijacking its machinery while dismantling its defenses and energy systems.

Epidemiology and Clinical Significance in Cattle

Bovine adenoviruses (BAdVs) represent a diverse and globally distributed group of pathogens that impose a substantial, yet often underappreciated, burden on cattle health and productivity. Their significance is multifaceted, ranging from their direct role as primary etiological agents of clinical disease to their more insidious contribution as co-factors within the bovine respiratory disease complex (BRDC) and enteric disease syndromes. A comprehensive understanding of their epidemiology and clinical impact is essential for the development of effective surveillance, control, and therapeutic strategies.

Global Prevalence and Serological Landscape

The epidemiological footprint of BAdVs is vast, with serological evidence indicating near-ubiquitous exposure in cattle populations worldwide. A landmark systematic review and meta-analysis, synthesizing data from diverse geographical regions and detection methodologies, revealed a stark dichotomy in prevalence estimates depending on the diagnostic approach employed [2]. In general cattle populations, the seroprevalence of BAdV was remarkably high at 0.66 (66%), underscoring the widespread nature of infection. This figure rose even further when considering herd-level exposure, with an estimated 82% of herds harboring seropositive animals [2]. This near-universal exposure is corroborated by regional studies; for instance, a survey in Rio Grande do Sul, Brazil, found that 97.3% of 415 serum samples contained neutralizing antibodies against BAdV-3, with a significant proportion exhibiting high titers (>1:256) [14]. Similarly, a seroepidemiological investigation in Japan using a virus-neutralization test against BAdV-2 reported an astonishing 92.8% seropositivity among 1,325 cattle, with the positivity rate increasing with age, a pattern indicative of endemic, horizontal transmission [9]. These data collectively suggest that BAdV infections are an almost inescapable feature of the bovine life cycle, particularly in intensively managed herds.

However, the prevalence of active viral shedding, as detected by nucleic acid or antigen assays, presents a different picture. In clinically healthy animals, the prevalence of BAdV genome detection is relatively low (approximately 0.05), reflecting the virus’s ability to establish latent or persistent infections with intermittent reactivation [2]. This contrasts sharply with the situation in cattle exhibiting clinical signs, where the prevalence of nucleic acid detection jumps to 0.32 [2]. This discrepancy highlights a critical epidemiological principle: seropositivity indicates past or present exposure, while molecular detection signifies active viral replication and potential shedding. The World Organisation for Animal Health (WOAH) recognizes the importance of differentiating between these states for accurate disease surveillance and control program design.

Serotype-Specific Epidemiology and Emerging Strains

The genus Mastadenovirus and Atadenovirus encompass a growing number of BAdV serotypes, each with distinct epidemiological profiles and pathogenic potential. BAdV-3, a member of the Mastadenovirus genus, is arguably the most extensively studied and is consistently identified as a dominant serotype in respiratory disease outbreaks. The meta-analysis confirmed its high prevalence in general cattle populations (0.87), though in clinically affected animals, its prevalence (0.27) was comparable to that of BAdV-7 (0.32) [2]. This suggests that while BAdV-3 is highly endemic, its clinical expression may be more dependent on host factors, co-infections, or specific viral genotypes.

The emergence of novel BAdV-3 genotypes with significant genetic alterations is a critical concern. A study in China from 2016 to 2018 detected BAdV-3 in 78.7% of nasal swabs from cattle with BRDC [10]. Crucially, a novel strain, BO/YB24/17/CH, was isolated that harbored a natural 79-amino-acid deletion in the shaft domain of the fiber gene, along with 74 unique amino acid mutations [10]. This deletion, which defines a novel fiber genotype, was found in 7 of 10 sequenced strains and was detected on six farms where calves had been imported from five different provinces, indicating a wide geographical dissemination [10]. The fiber protein is the primary determinant of host cell tropism, and such a substantial deletion could alter receptor binding, tissue tropism, and potentially pathogenicity. Experimental infection of BALB/c mice with this deletion strain demonstrated that, unlike previously reported BAdV-3 strains, it could be detected in multiple organs including the heart, liver, spleen, and kidney, suggesting a potential for systemic spread that may not be captured by standard respiratory-focused diagnostics [3]. This finding underscores the dynamic evolutionary nature of BAdV-3 and the need for continuous molecular surveillance.

BAdV-7, now classified within the genus Atadenovirus, represents another significant serotype with a distinct epidemiology. Its genome is characterized by a high AT content and a more compact organization compared to mastadenoviruses [21]. Complete genome sequencing of the Japanese prototype strain Fukuroi, isolated from a cow with respiratory disease, revealed it possesses the shortest inverted terminal repeats among all known adenoviruses [7]. The live attenuated vaccine strain TS-GT, used in Japan, has been sequenced, revealing a 99.9% identity to the pathogenic Fukuroi strain but with a novel mutation and four indels that are proposed as biomarkers for virulence attenuation [8]. The first complete genome sequence of a European BAdV-7 strain, isolated from a systemically infected newborn Limousin calf in Germany, has further expanded our understanding of its genetic diversity [5]. This strain, which caused severe systemic lesions with intranuclear inclusions in endothelial cells, groups closely with a recent US strain (SD18-74), confirming its transcontinental distribution [5].

Beyond these well-known serotypes, the epidemiological landscape is becoming more complex. BAdV-2, a Mastadenovirus associated with mild respiratory disease, was isolated for the first time in Japan from cattle with severe respiratory symptoms [9]. Its whole-genome sequence revealed notable differences in the E3 region compared to the prototype, which may affect its biological properties and pathogenicity [9]. Furthermore, the first DNA sequence evidence for the occurrence of BAdV-10 (Atadenovirus) and a novel BAdV-11 (Mastadenovirus) in continental Europe was reported in Hungary [6]. These viruses were detected in calves with intermittent diarrheal illness post-weaning, and in one case, a co-infection of BAdV-6 and BAdV-10 was identified [6]. This discovery marks a significant shift in the circulating types of BAdVs in the region and highlights the potential for previously rare or geographically restricted serotypes to emerge as significant pathogens.

Clinical Significance: From Respiratory to Systemic Disease

The clinical manifestations of BAdV infection are highly variable, ranging from subclinical to severe, and are influenced by viral serotype, strain virulence, host age, immune status, and the presence of concurrent infections. The most prominent clinical syndromes are respiratory and enteric, but systemic and other manifestations are increasingly recognized.

Bovine Respiratory Disease Complex (BRDC): BAdVs, particularly BAdV-3 and BAdV-7, are established contributors to the multifactorial BRDC [2, 16]. A multiplex qPCR study of 224 naturally diseased cows in China identified BAdV-3 as the second most frequently detected viral pathogen, with a detection rate of 22.32%, surpassed only by Mycoplasma bovis (27.23%) [16]. Importantly, 25% of the diseased cattle were infected with two or more of the six tested pathogens, underscoring the synergistic role of BAdV in polymicrobial respiratory disease [16]. The virus damages the respiratory epithelium, disrupting mucociliary clearance and creating a permissive environment for secondary bacterial invaders such as Mannheimia haemolytica and Pasteurella multocida. Experimental infections with BAdV-3 have demonstrated that clinical infection can reduce dietary nitrogen digestibility and increase urinary nitrogen excretion, contributing to metabolic stress and weight loss [20]. In calves, infection is often characterized by pyrexia, serous to mucopurulent nasal discharge, conjunctivitis, and coughing [19]. The disease is typically most severe in young calves, particularly those between 1 and 4 weeks of age, where it can lead to significant morbidity [19].

Enteric Disease and Systemic Infections: BAdVs are also recognized as causes of gastroenteritis, particularly in calves. The classic study by Mattson (1973) described a naturally occurring infection in a large beef herd where calves developed excessive ocular and nasal discharges, tympanites, colic, and diarrhea, with the disease onset closely associated with viral isolation [19]. BAdV-7 has been implicated in severe enteric disease, and the German isolate from a systemically infected calf demonstrated that the virus can cause a disseminated infection, with intranuclear inclusion bodies observed in endothelial cells of multiple peripheral tissues, including the spleen and liver [5]. This systemic potential is further supported by the isolation of BAdV-5 from calves with "weak calf syndrome," a condition characterized by polyarthritis, weakness, and high mortality [37, 38]. Experimental inoculation of colostrum-deprived calves with BAdV-5 reproduced lesions resembling the naturally occurring syndrome, confirming its etiological role [37]. The novel BAdV-3 fiber deletion strain also exhibited systemic spread in a mouse model, being detected in the heart, liver, spleen, kidney, and blood, which raises the possibility of a broader tissue tropism in cattle than previously appreciated [3].

Subclinical Infections and Economic Impact: A defining feature of BAdV epidemiology is the high rate of subclinical infection. The vast majority of infections, particularly in older animals with prior immunity, are asymptomatic. However, even subclinical infections are not without consequence. They can cause transient immunosuppression, reduce feed efficiency, and contribute to the overall disease burden within a herd. The study by Na et al. (1986) demonstrated that even subclinical BAdV-3 infection could reduce dietary nitrogen digestibility [20]. This chronic, low-level impact on productivity, when multiplied across a large herd, represents a significant, albeit difficult to quantify, economic loss. The presence of BAdV genomes in air and surface samples in dairy processing areas also highlights a potential occupational exposure risk for workers, though the zoonotic potential of BAdVs is considered low [36].

Pathogenesis and Host-Virus Interactions

The clinical significance of BAdV is deeply rooted in its molecular pathogenesis. The virus initiates infection by binding to host cell receptors; BAdV-3, for instance, utilizes sialic acid moieties on glycoproteins as a primary receptor for entry into MDBK cells, a mechanism distinct from the coxsackievirus-adenovirus receptor used by many human adenoviruses [18]. Following entry, the virus hijacks the host cellular machinery. The core protein V, a Mastadenovirus-specific protein, is critical for capsid stability and genome release, and its nucleolar localization signals are essential for the production of stable, infectious progeny virions [1, 25]. Protein VII, another core protein, is required for efficient assembly of mature virions and for the release of the virus from endosomes; its absence leads to the production of non-infectious particles [24]. The late protein VIII interacts with eukaryotic initiation factor 6 (eIF6), impairing the formation of functional 80S ribosomes and thereby inhibiting cellular mRNA translation, a strategy that favors the translation of viral mRNAs [27]. Furthermore, pVIII targets DDX3, interfering with the recruitment of translation initiation factors to the mRNA cap, providing another mechanism for host translational shutoff [29]. The 33K protein, a key regulator of late gene expression, binds to the major late promoter and requires specific leucine and arginine residues for its function, with the arginine residues being essential for transportin-3-mediated nuclear transport and virus replication [30, 31]. Infection with BAdV-3 also induces profound mitochondrial dysfunction, characterized by dissolution of cristae, altered membrane potential, and a surge in reactive oxygen species at late stages of infection, contributing to cellular oxidative stress and eventual cell death [35]. These intricate molecular interactions collectively determine the virus’s ability to replicate, evade host defenses, and cause tissue damage, ultimately dictating the clinical outcome.

Diagnostics and Laboratory Detection Methods

The accurate and timely diagnosis of bovine adenovirus (BAdV) infection is a cornerstone of effective disease management within the cattle industry, yet it remains a formidable challenge due to the remarkable diversity of viral types, the overlapping clinical presentations with other bovine respiratory and enteric pathogens, and the frequent occurrence of subclinical infections. The diagnostic landscape for BAdV has evolved considerably from classical virological techniques to sophisticated molecular and serological platforms, each offering distinct advantages and limitations that must be carefully weighed in both clinical and research settings. The complexity is further compounded by the fact that BAdVs are classified into two distinct genera, Mastadenovirus (types 1, 2, 3, 9, 10, and 11) and Atadenovirus (types 4, 5, 6, 7, and 8), which exhibit significant genetic and antigenic divergence, necessitating genus-specific or even type-specific diagnostic approaches [6, 13]. The World Organisation for Animal Health (WOAH) recognizes the economic significance of bovine respiratory disease complex (BRDC), in which BAdV plays a substantial role, underscoring the need for robust, standardized diagnostic protocols to inform control strategies and vaccine development.

Virus Isolation and Propagation in Cell Culture

Historically, virus isolation has been regarded as the gold standard for BAdV detection, providing definitive proof of active infection and enabling subsequent characterization of viral isolates. The success of this approach is critically dependent on the selection of permissive cell lines and optimized culture conditions. A comprehensive optimization study demonstrated that the reference strain BAdV-3 “Adeno III WBR-1” could be efficiently adapted to several continuous cell lines, including BHK-21/13 (baby hamster kidney), Taurus-1 (calf kidney), KST (bovine embryo coronary vessel endothelium), LEK (bovine embryo lung epithelium), and MDBK (Madin-Darby bovine kidney) [39]. Among these, the MDBK cell line exhibited the highest sensitivity to infection, with a maximum viral titer of (6.55 ± 0.21) log₁₀ TCID₅₀/cm² achieved using the roller cultivation method at a multiplicity of infection (MOI) of 0.0001, with peak accumulation observed at 24 hours post-infection [39]. This finding is particularly relevant for diagnostic laboratories seeking to maximize viral yield for downstream applications such as antigen production or genomic sequencing.

The choice of cell line can also influence the success of isolation for different BAdV types. For instance, the first isolation of BAdV-7 in Germany from a systemically infected calf was readily achieved using bovine esophagus cells (KOP-R), a strategy that proved superior to other cell lines for this particular atadenovirus [5]. Similarly, the Chinese isolate BAdV-3 HLJ0955 was successfully propagated in MDBK cells, where it produced characteristic cytopathic effects (CPE) including cell rounding, detachment, and the formation of intranuclear inclusion bodies [17]. The recent isolation of a novel BAdV-3 strain with a natural deletion in the fiber gene (BO/YB24/17/CH) was also accomplished in MDBK cells, highlighting the continued utility of this cell line for isolating emerging variants [3, 10]. However, it is crucial to recognize that not all BAdV types replicate efficiently in standard cell lines; BAdV-10 and BAdV-11, for example, have been detected primarily through molecular methods rather than isolation, suggesting that their in vitro cultivation may require specialized conditions [6]. The development of antigen production protocols has further refined isolation techniques, with one study demonstrating that purification of BAdV subgroup 1 antigen from BHK-21/13 cells using PEG-6000 precipitation followed by cesium chloride density gradient ultracentrifugation yielded three distinct antigenic fractions, the most purified of which contained a major 50.0 kDa protein and elicited an antibody titer of 1:3200 in immunized rabbits [22]. This work underscores the potential of optimized isolation and purification methods for generating high-quality diagnostic reagents.

Molecular Detection Methods: PCR and Quantitative Real-Time PCR

The advent of polymerase chain reaction (PCR) has revolutionized BAdV diagnostics, offering unparalleled sensitivity, specificity, and speed compared to virus isolation. Given the genetic heterogeneity among BAdV types, a nested PCR strategy has been advocated to ensure broad-spectrum detection across both Mastadenovirus and Atadenovirus genera. One such test system employs a common external primer pair for initial amplification, followed by genus-specific internal primers that discriminate between the two lineages [13]. This approach successfully identified the circulation of BAdV types 1, 3, 6, and 8 in field samples from calves with characteristic clinical signs, demonstrating its utility for epidemiological surveillance [13]. The nested PCR format is particularly advantageous for detecting mixed infections, which are common in BAdV epidemiology. In a study of diarrheic calves in Hungary, a high-sensitivity, broad-spectrum nested PCR revealed the simultaneous presence of BAdV-6 (Atadenovirus) and BAdV-10 (Mastadenovirus) in the same clinical sample, a finding that would have been missed by type-specific assays [6]. This work also led to the first molecular identification of BAdV-11 in continental Europe, highlighting the power of PCR-based approaches for discovering novel or emerging types [6].

Quantitative real-time PCR (qPCR) has become the method of choice for many diagnostic laboratories due to its ability to provide both qualitative detection and quantitative viral load data. The design of primers targeting conserved genomic regions is critical for assay robustness. For BAdV-3, the hexon gene has proven to be a reliable target, as demonstrated in a multiplex qPCR assay developed for the simultaneous detection of six major BRDC pathogens: bovine respiratory syncytial virus (BRSV), bovine parainfluenza virus type 3 (BPIV3), bovine viral diarrhea virus (BVDV), BAdV-3, Mycoplasma bovis, and infectious bovine rhinotracheitis virus (IBRV) [16]. This assay, targeting the hexon gene of BAdV-3, achieved a limit of detection of 74.4 copies/μL for the plasmid DNA standard, with coefficients of variation below 4% and amplification efficiencies ranging from 93.84% to 111.60%, indicating excellent reliability and stability [16]. When applied to 224 clinical samples from naturally diseased cattle, the assay detected BAdV-3 in 22.32% of cases, the second-highest prevalence among the six pathogens tested, and revealed a mixed infection rate of 25% [16]. These data underscore the critical role of BAdV-3 in BRDC and the necessity of multiplex approaches for comprehensive pathogen profiling.

Real-time PCR has also been instrumental in elucidating the pathogenesis and tissue tropism of BAdV-3 strains. In a study of the fiber-deletion mutant BO/YB24/17/CH in BALB/c mice, qPCR detection of viral DNA in multiple organs, including heart, liver, spleen, kidney, and blood, revealed a broader tissue distribution than previously reported for wild-type BAdV-3, which was thought to be restricted to the lungs and trachea [3]. This finding has significant implications for understanding the systemic potential of emerging BAdV-3 variants. Furthermore, qPCR has been adapted for environmental surveillance, with one study detecting BAdV genomes in 28.6% of air samples and 14.3% of surface samples from dairy processing facilities, with concentrations reaching 5.4 × 10¹ genome copies/m³ in air and 2.30 × 10² genome copies/100 cm² on surfaces [36]. This application highlights the potential for airborne and fomite transmission of BAdV and the utility of molecular methods for monitoring contamination in occupational settings.

Serological Assays: Virus Neutralization and Enzyme-Linked Immunosorbent Assay

Serological testing remains an indispensable tool for assessing population-level exposure, vaccine efficacy, and the immune status of individual animals. The virus neutralization (VN) test is considered the reference standard for detecting type-specific neutralizing antibodies, though it is labor-intensive and requires live virus and cell culture facilities. A large-scale serosurvey in Brazil using VN against BAdV-3 revealed that 97.3% of 415 serum samples were seropositive, with titers exceeding 1:256 in 72.2% of positive samples, indicating widespread and high-level exposure in the cattle population [14]. Similarly, a VN-based survey in Japan found that 92.8% of 1,325 cattle were seropositive for BAdV-2, with seropositivity increasing with age, suggesting endemic circulation and age-dependent acquisition of immunity [9]. These data are consistent with a recent systematic review and meta-analysis, which reported a pooled BAdV seroprevalence of 0.66 in general cattle populations using antibody detection methods, with herd-level seroprevalence reaching 0.82 [2]. The meta-analysis further revealed significant differences in seroprevalence between BAdV-3 (0.87) and BAdV-7 (0.21) in general populations, though both types showed similar prevalence (0.27 and 0.32, respectively) in clinically affected cattle, suggesting that serological profiles can inform type-specific epidemiological patterns [2].

Enzyme-linked immunosorbent assay (ELISA) offers a more high-throughput and less labor-intensive alternative to VN, and its performance is critically dependent on the quality of the antigen employed. The development of recombinant hexon protein (rhexon) as a diagnostic antigen has been a major advance. The hexon protein is a group-specific antigen that induces the formation of cross-reactive antibodies, making it an ideal target for broad-spectrum serological screening [26]. A recombinant N-terminal fragment of BAdV-3 hexon (503 bp) expressed in E. coli BL21/pET28/rhAdv3 yielded a 25 kDa protein with a hexa-histidine tag, which was confirmed by MS/MS analysis (Score 2033) and holds promise for use in ELISA-based test systems [26]. Another study demonstrated that purified rhexon protein could induce long-term antibody production for at least 16 weeks in both mice and goats, with significantly elevated levels of interferon-γ and interleukin-2, indicating a Th1-biased immune response [4]. These findings support the utility of recombinant hexon-based ELISAs not only for diagnostics but also for evaluating vaccine immunogenicity.

Indirect ELISA formats using purified viral antigens have also been developed. The purification of BAdV subgroup 1 antigen from cesium chloride gradients yielded a fraction with a 50.0 kDa major protein that exhibited maximum antigenic activity, and rabbits immunized with this fraction produced antibody titers of 1:3200 by day 45 post-immunization [22]. Such purified antigens can serve as coating antigens for ELISA, providing a standardized and reproducible platform for large-scale serosurveillance. The choice between VN and ELISA depends on the specific diagnostic objective: VN provides type-specificity and functional antibody titers, while ELISA offers higher throughput and the ability to detect group-specific antibodies, making it more suitable for screening purposes.

Antigen Detection Methods: Immunofluorescence and Immunohistochemistry

Direct detection of viral antigens in clinical specimens or tissues provides rapid confirmation of active infection and can be performed without the need for virus isolation. The direct fluorescent antibody technique (FAT) has been applied to nasal swab samples for the detection of BAdV-3 in calves. In a study conducted in Nineveh province, 44% of 200 nasal swabs from calves of various ages tested positive by immunofluorescence, with the highest prevalence observed in calves aged 6–9 months and in exotic breeds (50.3%) compared to local breeds (22.2%) [12]. The study also found that calves with respiratory signs had a significantly higher prevalence than clinically healthy animals, supporting the diagnostic utility of FAT for identifying active BAdV-3 infection in respiratory disease outbreaks [12]. Immunohistochemistry (IHC) has been employed to localize viral antigens in tissues from experimentally infected animals. In BALB/c mice inoculated with the BAdV-3 fiber-deletion strain BO/YB24/17/CH, IHC confirmed that histopathological lesions, including alveolar septal thickening, splenic nodule dilation, and pulmonary hemorrhage, were directly attributable to viral infection, with positive staining observed in lung, trachea, spleen, and other organs [3]. This technique is particularly valuable for understanding viral pathogenesis and for confirming the etiology of lesions observed during necropsy.

Advanced and Emerging Techniques: Next-Generation Sequencing and Cryo-Electron Microscopy

The application of next-generation sequencing (NGS) has transformed our ability to characterize BAdV genomes at an unprecedented resolution, facilitating the discovery of novel types, the tracking of evolutionary dynamics, and the identification of virulence determinants. The complete genome sequence of the European BAdV-7 strain from Germany was obtained directly from pooled spleen and liver tissue using NGS, revealing a genome organization typical of atadenoviruses and enabling phylogenetic analysis that placed the strain closest to the US isolate SD18-74 [5]. Similarly, NGS was used to determine the complete genome of the Japanese BAdV-7 prototype strain Fukuroi (30,034 bp), which was found to have the shortest inverted terminal repeats among known adenoviruses [7]. Comparative genomics of the live attenuated BAdV-7 vaccine strain TS-GT against the pathogenic Fukuroi strain identified a novel mutation and four indels that may serve as biomarkers for virulence attenuation, providing a molecular basis for vaccine safety assessment [8]. The first complete genome sequence of a Japanese BAdV-2 strain (KY19-1) was also determined by NGS, revealing 99.1% nucleotide identity with the prototype No. 19 strain but notable differences in the E3 region, which may affect pathogenicity [9].

Cryo-electron microscopy (cryo-EM) has provided structural insights that can inform diagnostic antigen design. The recent cryo-EM structure of BAdV-3 at near-atomic resolution revealed atomic models for previously uncharacterized regions of minor protein VI and core proteins V and Mu, demonstrating how these proteins bridge the capsid and genomic core [1]. Such structural information can guide the selection of epitopes for recombinant antigen production and the design of serological assays targeting conformation-dependent antibodies. While not yet a routine diagnostic tool, cryo-EM represents a powerful research technique that will likely influence the next generation of diagnostic reagents.

Comparative Performance of Detection Methods

The choice of diagnostic method has a profound impact on observed prevalence estimates and the interpretation of epidemiological data. A comprehensive meta-analysis directly compared detection methods and found that antibody detection methods yielded a BAdV prevalence of 0.66 in general cattle populations, whereas nucleic acid detection methods yielded only 0.05 in the same population [2]. This discrepancy reflects the fact that seropositivity indicates past exposure and may persist long after viral clearance, while nucleic acid detection indicates current or recent infection. In clinically affected cattle, nucleic acid detection methods showed a prevalence of 0.32, compared to 0.06 for antigen detection methods, highlighting the superior sensitivity of PCR-based approaches for detecting active infection [2]. These findings have important implications for diagnostic algorithms: serological surveys are appropriate for assessing population-level exposure and herd immunity, while molecular methods are essential for confirming active cases and for outbreak investigations. The integration of multiple diagnostic modalities, combining serology for screening with PCR for confirmation, provides the most comprehensive approach to BAdV surveillance and control.

Cultivation and Propagation Optimization for Bovine Adenovirus

The optimization of cultivation and propagation protocols for bovine adenoviruses (BAdVs) constitutes a cornerstone of contemporary virological research, diagnostic development, and vaccinology. Given the significant economic burden imposed by BAdV infections, particularly within the bovine respiratory disease complex (BRDC) and enteric disease syndromes in calves, the establishment of robust, reproducible, and high-yield in vitro systems is not merely an academic exercise but a critical prerequisite for advancing both fundamental understanding and applied interventions [2, 22, 39]. The World Organisation for Animal Health (WOAH) recognizes the importance of standardized diagnostic methodologies for economically impactful pathogens of cattle; thus, the optimization of viral cultivation directly underpins the reliability of serological and molecular detection platforms used in national surveillance programs. This section provides an exhaustive analysis of the biological determinants, methodological refinements, and strategic considerations that govern the successful cultivation and propagation of BAdV, drawing upon a diverse body of recent and foundational literature.

The Foundation: Cell Substrate Selection and Permissivity

The selection of an appropriate cell line is the most fundamental variable in the successful propagation of any virus, and BAdVs are no exception. The inherent permissivity of a cell line dictates not only whether a virus can initiate replication but also the ultimate yield of infectious progeny. The reference strain for bovine adenovirus subgroup 1, “Adeno III WBR – 1,” as investigated by Mukhammadiev et al. (2025), has been systematically evaluated across a panel of continuous cell lines, including newborn Syrian hamster kidney (BHK-21/13), calf kidney (Taurus-1), coronary vessel endothelium from embryonic cow (KST), embryonic bovine lung epithelium (LEK), and the widely utilized Madin-Darby bovine kidney (MDBK) cell line [39]. The results of this systematic evaluation are instructive. While the virus demonstrated rapid adaptation to stationary cultivation methods across BHK-21/13, Taurus-1, KST, and MDBK lines, it was the MDBK cell line that exhibited the highest sensitivity to infection, achieving maximal viral accumulation at a remarkably low multiplicity of infection (MOI) of 0.0001 plaque-forming units per cell [39]. This observation underscores a critical principle: the efficiency of infection is not solely a function of cell availability but is profoundly influenced by the density and affinity of specific viral receptors on the cell surface. MDBK cells, being of bovine kidney origin, likely present a constellation of surface sialoglycoproteins that are optimally recognized by the BAdV-3 fiber knob domain.

Indeed, the molecular basis for this cellular tropism has been elegantly elucidated by Li et al. (2009), who demonstrated that BAdV-3 utilizes sialic acid moieties as its primary cellular receptor [18]. Unlike human adenoviruses that engage the coxsackievirus and adenovirus receptor (CAR), BAdV-3 entry is CAR-independent and entirely reliant on interactions with α(2,3)- and α(2,6)-linked sialic acid residues presented on cell surface glycoproteins [18]. Virus overlay protein binding assays (VOPBA) identified specific sialylated membrane proteins of approximately 97 kDa and 34 kDa as binding partners for BAdV-3 virions [18]. This mechanistic insight is of paramount importance for cultivation optimization; it suggests that cell lines with rich, diverse sialoglycoproteomes, such as the epithelial-like MDBK cells, will inherently support more robust viral entry and subsequent propagation. Furthermore, the tropism extends to other cell types. For instance, the isolation of a novel BAdV-7 strain (genus Atadenovirus) from a systemically infected calf in Germany was successfully achieved using bovine esophagus cells (KOP-R), a strategy that proved readily accessible and effective, suggesting that primary or semi-continuous cell lines derived from the bovine respiratory or gastrointestinal tract also provide a permissive environment [5]. The choice between continuous lines (e.g., MDBK, BHK-21) and primary or low-passage lines involves a trade-off between convenience and biological fidelity; continuous lines offer standardization and ease of use, while primary lines may more faithfully recapitulate in vivo cellular states, potentially improving isolation efficiency for fastidious or novel viral strains [5, 17].

Methodologies and Temporal Dynamics: Maximizing Viral Yield

Beyond simple cell line selection, the specific cultivation methodology exerts a profound influence on the final viral titer. The transition from static, monolayer culture to dynamic systems represents a significant optimization step. Mukhammadiev et al. (2025) conducted a comparative assessment of viral yield using the MDBK cell line under different cultivation regimes [39]. Their findings are unequivocal: the roller bottle method of cell cultivation dramatically outperformed stationary culture, yielding a maximum titer of (6.55 ± 0.21) log TCID50/cm² [39]. This approximately 10- to 100-fold increase in titer is attributable to several synergistic factors. Roller cultivation enhances oxygen and nutrient transfer to the cell monolayer, reduces the accumulation of metabolic waste products in the immediate microenvironment, and increases the total surface area available for cell growth per unit volume of media. The constant gentle agitation also likely facilitates more uniform viral adsorption and spread, preventing the localized depletion of susceptible cells that can occur in static flasks. Additionally, the harvesting timeline is critical. The maximum accumulation of the BAdV-3 strain in the culture fluid was observed at just 24 hours post-infection for this system, indicating a rapid replication cycle under optimized conditions [39]. This short incubation window has significant practical implications for vaccine production and antigen preparation, allowing for rapid, high-throughput viral stock generation.

The production of viral biomass for antigen purification, as detailed by Yarullin et al. (2025), further refines these principles [22]. In their protocol, roller cultivation of infected BHK-21/13 cells was followed by ultrasonic disruption of the cellular matrix to release intracellular virions, differential centrifugation to clarify the lysate, and precipitation of viral particles using polyethylene glycol (PEG-6000) [22]. The final step involved ultracentrifugation through a stepwise cesium chloride gradient, a classic but powerful method that resolves three distinct antigenic fractions. The most purified fraction, containing a major 50.0 kDa region corresponding to the hexon protein, exhibited maximum serological activity, inducing an antibody titer of 1:3200 in immunized rabbits by day 45 post-immunization [22]. This sequence of steps, from dynamic cell culture to physicochemical purification, epitomizes the engineering approach required to transition from laboratory-scale research to the production of diagnostic and vaccine-grade antigens. The use of PEG precipitation and CsCl gradient ultracentrifugation, while labor-intensive, remains the gold standard for producing highly pure, concentrated viral stocks free from cellular contaminants that could otherwise interfere with downstream applications such as ELISA, Western blotting, or inactivated vaccine formulation.

Molecular and Structural Considerations for Enhanced Yield

An advanced understanding of the BAdV life cycle at the molecular and structural level provides a rational basis for further cultivation optimization. The work by Xiao et al. (2025) on the cryo-electron microscopy architecture of BAdV-3 has illuminated the critical roles of core proteins V and Mu, and minor protein VI, in bridging the viral genome to the capsid and ensuring capsid stability [1]. The stability of the mature virion is not merely a structural curiosity; it directly impacts the efficiency of downstream purification and the shelf-life of viral preparations. Understanding that protein V, in particular, acts as a "molecular glue" strengthening the capsid suggests that factors which compromise capsid integrity, such as freeze-thaw cycles, improper pH, or suboptimal buffer composition, will have a disproportionately large effect on viral infectivity and yield [1]. Consequently, meticulous attention to the formulation of the harvesting and storage buffers is essential. The inclusion of stabilizing agents like sucrose or trehalose, and maintenance of a physiological pH range (7.2-7.4), are recommended practices derived from this structural knowledge.

Furthermore, research into specific viral proteins has identified potential bottlenecks in the assembly process that can be targeted for optimization. The core protein VII, while the subject of recent retractions, was originally characterized as essential for the production of infectious progeny virions [23, 24, 33, 34]. The requirement for a protein VII-complementing cell line to rescue VII-deleted BAdV-3 underscores that certain viral proteins are absolutely indispensable for assembly [24]. Critically, the absence of protein VII not only reduced assembly efficiency but also altered the proteolytic cleavage of protein VI and impaired the release of virions from endosomes during subsequent rounds of infection [24]. This highlights a crucial feedback loop: the quality of the progeny virions produced in a given cultivation system is directly influenced by the efficiency of the assembly machinery. In practice, if the production cell line is stressed or nearing senescence, the post-translational processing of key structural proteins (e.g., the cleavage of pVI by the adenoviral protease) may be suboptimal, leading to the accumulation of non-infectious or thermolabile particles. Similarly, the pIX protein has been demonstrated to be essential for the rescue of full-length BAdV-3 genomes in transfection experiments; deletion of pIX or mutation of its initiation codon completely abrogated progeny virion production [28]. The conserved N-terminus and a putative leucine zipper element (PLZP) of pIX are critical for this function, suggesting that interventions to stabilize or enhance pIX expression could theoretically boost rescue efficiency in recombinant systems [28]. The nuclear and nucleolar localization signals of proteins V and IVa2, and the role of leucine zippers in 33K protein binding to the major late promoter, all represent potential molecular targets for genetic engineering of producer cell lines to enhance viral gene expression and assembly [11, 25, 30].

Propagation for Vaccine and Vector Applications: Recombinant Systems

The optimization of BAdV cultivation has been driven not only by the need for diagnostic reagents but also by the immense potential of BAdVs as vaccine delivery vectors. The development of replication-competent bovine adenovirus type 3 recombinants, as exemplified by the work of Baxi et al. (2000), demonstrates that the E3 region can be deleted or manipulated to accommodate foreign antigen expression cassettes without crippling viral replication [43]. The insertion of the bovine viral diarrhea virus (BVDV) E2 glycoprotein gene into the E3 region under the control of the BAdV-3 major late promoter (MLP) or a human cytomegalovirus immediate early promoter was successfully achieved. Importantly, the insertion did not affect the replication kinetics of the recombinant virus in cell culture, and intranasal immunization of cotton rats elicited robust mucosal (IgA) and systemic (IgG) antibody responses [43]. This finding has significant implications for cultivation optimization: while the recombinant virus replicates with similar efficiency to the wild-type in permissive cells, the production of such vectors must be carefully monitored to ensure genetic stability. The E3 region is non-essential for replication in cell culture, but deletions or insertions can alter the cytopathic effect or growth kinetics, necessitating the development of specific quality control assays (e.g., PCR for insert integrity, sequencing of flanking regions) during large-scale production.

The utility of human adenovirus type 5 (rAd5) as a vector for expressing bovine pathogen antigens further broadens the cultivation landscape, albeit for a heterologous system. The construction of a bivalent rAd5 expressing VP1 proteins of bovine norovirus and bovine nebovirus, and a rHAd5 expressing the F and HN proteins of bovine parainfluenza virus type 3, demonstrates a trend toward using well-characterized human adenovirus platforms for veterinary vaccine development [40, 41]. These constructs are propagated in human cell lines (e.g., HEK293 cells), which are engineered to complement the E1 deletion that renders the virus replication-defective. For veterinary researchers, this means that cultivation optimization for BAdV-based vectors must be juxtaposed with the option of using human adenovirus vectors, which benefit from decades of optimization for human gene therapy and vaccine production. The choice between a homologous (BAdV) and a heterologous (HAdV) vector system involves considerations of pre-existing immunity in the target species, the desired route of administration (e.g., oral vs. intramuscular), and the regulatory landscape for veterinary biologics. The molecular characterization of the BAdV genome, including the identification of unique deletions in fiber (79 amino acids in the shaft domain) in circulating Chinese strains, further complicates this landscape by revealing significant genotypic diversity that must be accounted for in vector design and propagation [3, 10].

Quality Control, Standardization, and Biosecurity Implications

The ultimate goal of cultivation optimization is to produce viral preparations of known quantity, quality, and sterility. The development of highly sensitive and specific detection methods, such as the multiplex qPCR assay established by Li et al. (2025), facilitates the monitoring of viral replication kinetics and the detection of adventitious agents that could contaminate cell culture [16]. This assay, targeting the hexon gene of BAdV-3 among other BRDC pathogens, boasts a detection limit of 74.4 copies/μL for BAdV-3 DNA, with high amplification efficiency (93.84–111.60%) and low inter-assay variability [16]. In a cultivation context, such a tool is invaluable for determining the optimal time to harvest (peak genome copy number) and for verifying the purity of the stock. The high seroprevalence of BAdV in cattle populations, as high as 82% at the herd level in some meta-analyses, underscores the ubiquity of these viruses and reinforces the need for stringent quality control during vaccine production to prevent the inadvertent introduction of field strains into cell lines [2, 14].

Finally, the cultivation of BAdV must be conducted under appropriate biosecurity conditions. While BAdVs are not considered zoonotic in the same manner as influenza viruses, the presence of BAdV DNA has been documented in air and surface samples within dairy production environments, indicating potential for occupational exposure [36]. Furthermore, studies have demonstrated the virucidal activity of water-soluble tetra-cationic porphyrins against BAdV in vitro, offering a potential avenue for decontamination of laboratory surfaces and solutions [42]. The implementation of rigorous biosafety level 2 (BSL-2) practices, including the use of biological safety cabinets, proper waste decontamination, and regular testing of cell lines for mycoplasma and other contaminants, is non-negotiable for any laboratory engaged in the propagation of these agents. The use of roller bottles, while increasing yield, also increases the risk of contamination if proper aseptic technique is not maintained, as the increased surface area and dynamic culture environment can favor the growth of bacterial or fungal contaminants. Therefore, the optimization of cultivation is not a purely biological endeavor; it is inherently intertwined with engineering controls, quality assurance protocols, and a deep respect for the infectious nature of the agent.

Advances in Bovine Adenovirus Research and Biotechnological Applications

The trajectory of bovine adenovirus (BAdV) research over the past two decades has been nothing short of transformative, shifting from a primarily descriptive virology discipline focused on disease pathology to a sophisticated molecular enterprise that exploits the unique biology of these viruses for diagnostic, therapeutic, and prophylactic purposes. This evolution has been driven by a confluence of technological breakthroughs, most notably in cryo-electron microscopy (cryo-EM), next-generation sequencing, and recombinant DNA technology, that have illuminated fundamental aspects of BAdV structure, replication, and pathogenesis while simultaneously enabling the rational design of vectored vaccines and novel antiviral strategies. The World Organisation for Animal Health (WOAH) recognizes adenoviral infections as significant contributors to the bovine respiratory disease complex (BRDC), a multifactorial syndrome that imposes enormous economic burdens on the global cattle industry, making advances in this field directly relevant to food security and animal welfare.

Structural and Molecular Dissection of the BAdV Virion

A seminal advance in the field is the near-atomic resolution structure of the BAdV-3 virion, solved by cryo-EM, which has revealed previously uncharacterized details of the capsid–genome interface [1]. This structural tour de force demonstrates significant conservation with human adenoviruses but provides atomic models for regions of minor protein VI and core proteins V and Mu that were previously recalcitrant to structural characterization. The work underscores how core proteins form an intricate molecular bridge between the viral genome and the inner capsid surface, a finding that has profound implications for understanding genome packaging, capsid stability, and the mechanics of genome release upon entry. Specifically, protein V is revealed to play a multifaceted role: it strengthens capsid stability through electrostatic interactions with the DNA and contributes to the ordered disassembly process required for productive infection [1]. This structural information is not merely academic; it provides a blueprint for engineering BAdV vectors with enhanced thermostability or altered uncoating kinetics, properties that are critical for vaccine formulation and distribution in field settings where cold-chain integrity cannot be guaranteed.

Complementing these structural insights, a series of elegant studies have elucidated the molecular choreography of nuclear and nucleolar trafficking of key BAdV-3 proteins. Protein V, encoded by the L2 region, contains multiple overlapping nuclear localization signals (NLS) and nucleolar localization signals (NoLS) that direct it to the nucleolus of infected cells [25]. The presence of these NoLS is not optional, deletion of both NoLS is lethal for virus production, and virions lacking these signals are thermolabile, exhibiting disrupted capsids and reduced infectivity [25]. This suggests that the nucleolar targeting of pV is mechanistically coupled to the assembly of stable, infectious progeny. Similarly, protein IVa2, encoded by the intermediate region, utilizes importin α-1 for nuclear import and contains distinct domains for nucleolar localization, with amino acids 120–140 mediating critical interactions with pV [11]. The 22K and 33K proteins, arising from the L6 region, further illustrate the complexity of nuclear transport. The 33K protein employs both classical importin-α/β and importin-β-dependent pathways, preferentially binding importin-α5 and transportin-3 [31]. Mutation of arginine residues within the RS repeat of 33K is lethal for virus replication, underscoring the essential nature of transportin-3-mediated nuclear import [31]. The 22K protein, by contrast, utilizes importin-α5 and α-7, and its nuclear localization depends on a non-conserved C-terminal region containing a 238RRRK241 motif [44]. Collectively, these findings paint a picture of a virus that has evolved redundant, yet highly specific, nuclear import strategies to ensure the timely delivery of structural and regulatory proteins to their sites of action.

The core protein VII has historically been a focus of intense investigation, though recent retractions of key papers by Kulanayake et al. [23, 24, 33, 34] warrant caution in interpreting that specific body of work. The retracted articles claimed that protein VII is required for efficient production of infectious virions, that it interacts with IVa2 and protein VIII via specific amino acid regions, and that its absence alters proteolytic cleavage of protein VI and endosomal escape. While the retractions, issued in 2025 due to concerns about the validity of the data, create a gap in the literature, the fundamental question of protein VII function remains important. Future studies employing independently derived reagents and rigorous experimental controls will be essential to establish the bona fide roles of this multifunctional core protein.

Mechanisms of Host Cell Manipulation and Pathogenesis

Beyond structural biology, significant progress has been made in understanding how BAdV-3 subverts the host cellular machinery to create a permissive environment for replication. One of the most striking discoveries is the role of protein VIII in the translational shutoff of host mRNAs, a hallmark of late adenovirus infection. Protein VIII interacts with eukaryotic initiation factor 6 (eIF6), a factor that regulates the assembly of the 80S ribosome [27]. This interaction, mapped to the C-terminus of pVIII (amino acids 147–174) and the N-terminus of eIF6 (amino acids 44–97), leads to an accumulation of free 60S subunits and a reduction in functional 80S complexes [27]. The functional consequence is an impairment of cellular mRNA translation, but importantly, this does not extend to adenoviral late mRNAs, which are preferentially translated. This represents a sophisticated mechanism of host shutoff that is distinct from the proteolytic degradation strategies employed by other viruses. Further work has shown that pVIII also interacts with DDX3, a DEAD-box helicase, thereby interfering with the recruitment of eIF3, eIF4E, eIF4G, and PABP to the mRNA cap structure [29]. This dual mechanism, targeting both ribosome assembly and cap-dependent initiation, ensures a dramatic remodeling of the cellular translation landscape in favor of viral protein synthesis. The absence of direct pVIII interaction with eIF3, eIF4E, or PABP suggests that DDX3 is the central node through which pVIII exerts its effects [29].

The impact of BAdV-3 infection extends to mitochondrial physiology, with profound implications for cellular energy metabolism and redox balance. Electron microscopy of infected cells reveals extensive damage to the inner mitochondrial membrane, including dissolution of cristae and amorphous matrix changes, while the outer membrane remains largely intact [35]. Functionally, ATP production, mitochondrial Ca²⁺ levels, and mitochondrial membrane potential (MMP) all peak at 18 hours post-infection but then plummet by 24 hours. This decline coincides with a burst of superoxide and reactive oxygen species (ROS) production, indicating acute oxidative stress and a catastrophic failure of cellular homeostatic mechanisms [35]. The temporal correlation between increased ROS production and the late phase of viral replication suggests that BAdV-3 may deliberately induce mitochondrial dysfunction to create an environment favorable for virion assembly or release, or alternatively, that this damage is an unavoidable consequence of viral exploitation of mitochondrial resources. Understanding this interplay between viral replication and mitochondrial biology could open avenues for antiviral interventions that target mitochondrial function.

Epidemiology and Emergence of Novel Variants

The epidemiological landscape of BAdV infections is far more complex than previously appreciated. A comprehensive systematic review and meta-analysis encompassing diverse cattle populations and detection methods has provided robust prevalence estimates that vary dramatically by serotype and clinical context [2]. In the general cattle population, antibody-based detection reveals a BAdV prevalence of 0.66, with BAdV-3 alone accounting for 0.87 of infections. However, in cattle exhibiting clinical signs, BAdV-3 and BAdV-7 show remarkably similar prevalence (0.27 and 0.32, respectively), suggesting that BAdV-7, an atadenovirus, may be a more significant contributor to clinical disease than is often assumed [2]. Herd-based seroprevalence is strikingly high at 0.82, indicating that BAdV infections are ubiquitous in cattle populations worldwide. The method of detection profoundly influences apparent prevalence: nucleic acid detection yields a prevalence of only 0.05 in general populations versus 0.32 in clinical cases, while antigen detection in clinical cases gives a mere 0.06 [2]. This discrepancy highlights the limitations of individual diagnostic modalities and underscores the need for multi-platform surveillance strategies, particularly given the role of BAdVs in BRDC, a syndrome of paramount economic concern.

The detection of novel and emerging BAdV variants has accelerated with the application of molecular tools. In China, a novel BAdV-3 strain (BO/YB24/17/CH) harboring a natural 79-amino-acid deletion in the fiber shaft domain and 74 unique amino acid mutations was isolated from cattle with BRDC [10]. Remarkably, 7 of 10 strains screened possessed this novel fiber gene, and these strains were detected on six farms spanning five provinces, indicating wide geographical dissemination [10]. Experimental infection of BALB/c mice with this isolate demonstrated that, unlike previously characterized BAdV-3 strains that are largely restricted to the respiratory tract, this deletion variant could be detected in multiple organs including the heart, liver, spleen, kidney, and blood [3]. This expanded tropism raises concerns about enhanced pathogenicity and the potential for systemic disease. The fiber deletion likely alters receptor binding properties, as BAdV-3 is known to utilize sialic acid, both α(2,3)-linked and α(2,6)-linked forms, as a primary cellular receptor, engaging approximately 97 kDa and 34 kDa sialoglycoproteins on the host cell surface [18]. Deletions in the shaft domain could plausibly alter fiber flexibility, trimer stability, or receptor engagement kinetics, thereby broadening tropism.

European surveillance has also yielded important discoveries. The first complete genome sequence of a European BAdV-7 strain, isolated from a systemically infected newborn Limousin calf in Germany, was obtained by next-generation sequencing [5]. Histopathological examination revealed intranuclear amphophilic inclusions in endothelial cells across multiple peripheral tissues, confirming the systemic nature of BAdV-7 infection. The fiber gene was highly conserved among BAdV-7 strains but showed only 39.56% amino acid identity with ovine adenovirus 7 (OAdV-7), underscoring the genetic distinctiveness of this atadenovirus [5]. A variable region of multiple tandem repeats was identified between the E4.1 and RH5 coding regions, which may serve as a genetic marker for strain discrimination and epidemiological tracking. The Japanese BAdV-7 strain Fukuroi, isolated from a cow with respiratory disease, has a remarkably compact genome of only 30,034 bp with the shortest inverted terminal repeats known among adenoviruses [7]. Live attenuated BAdV-7 vaccine strain TS-GT, used in Japan, has 99.9% identity with the pathogenic Fukuroi strain but contains a novel mutation and four indels that may serve as biomarkers for virulence attenuation [8].

Even more striking is the first molecular evidence for the occurrence of BAdV types 10 and 11 in continental Europe, detected in sick and dead calves in Hungary [6]. Using a broad-spectrum nested PCR coupled with molecular cloning to resolve mixed amplicons, researchers demonstrated co-infections with BAdV-6 (Atadenovirus) and BAdV-10 (Mastadenovirus) in the same animals, as well as the identification of a proposed novel type, BAdV-11. This marks a significant shift in the types of BAdVs circulating in Europe and raises questions about the origins and transmission dynamics of these viruses. Additionally, the first isolation of BAdV-2 in Japan, from cattle with severe respiratory symptoms, revealed a genome of 33,175 bp with notable differences in the E3 region compared to the prototype [9]. Seroepidemiology demonstrated that 92.8% of Japanese cattle are seropositive for BAdV-2, with positivity increasing with age, suggesting widespread endemic circulation.

Biotechnological Applications: Vaccine Vectors and Diagnostics

The most transformative advances in BAdV research have been in their exploitation as biotechnological tools. Bovine adenovirus type 3, in particular, has emerged as a premier vaccine delivery vehicle for cattle, offering several advantages over human adenovirus vectors: it is species-specific, does not replicate in humans, and pre-existing immunity against human adenoviruses does not impair its efficacy in cattle [32]. Both replication-competent and replication-deficient BAdV-3 vectors have been developed, and the early region 3 (E3) has proven to be a particularly suitable site for transgene insertion, as it is non-essential for viral replication in vitro [43]. A landmark study demonstrated that recombinant BAdV-3 expressing the glycoprotein E2 of bovine viral diarrhea virus (BVDV) induced robust E2-specific IgA and IgG responses at mucosal surfaces and in serum following intranasal immunization of cotton rats [43]. The use of the bovine herpesvirus 1 glycoprotein D signal sequence to ensure proper processing of the E2 glycoprotein was a key design feature that enabled the expression of a 53-kDa protein that formed functional dimers.

More recent work has extended this platform to multivalent vaccines. A bivalent recombinant human adenovirus type 5 (rAd5) vector expressing VP1 proteins of both bovine norovirus and bovine nebovirus induced significant VP1-specific IgG titers in mice (peak 1:10⁵) and calves, with serum blocking titers (BT50) reaching 640 in intramuscularly immunized mice and 80 in calves [40]. Importantly, the percentage of IL-4-producing cells and CD3⁺CD8⁺ T cells was significantly elevated, indicating robust cellular immune responses [40]. Similarly, a recombinant Ad5 vector expressing both the fusion (F) and hemagglutinin-neuraminidase (HN) glycoproteins of bovine parainfluenza virus type 3 (BPIV3) induced higher antibody levels than vectors expressing either protein alone, with HI titers of 1:1024 and neutralizing antibody titers of 1:426 in calves [41]. These dual-expression vectors represent a significant advance in the effort to develop multivalent, single-administration vaccines that can protect against multiple BRDC pathogens simultaneously.

The development of BAdV type 1 infectious clones has expanded the vector repertoire. Ren et al. [45] constructed the first infectious clone of BAdV-1 expressing enhanced yellow fluorescent protein (EYFP), demonstrating stable expression over multiple passages and neutralization titers consistent with wild-type virus. This provides a foundation for BAdV-1-based vectored vaccines that could complement existing BAdV-3 platforms, particularly if differential immune responses or tissue tropisms prove advantageous for specific applications. The utility of BAdV-1 is further supported by the high seroprevalence of BAdV-1 antibodies in cattle populations, indicating that this serotype is well-adapted to the bovine host.

Subunit vaccine development has also progressed, most notably with the recombinant hexon protein of BAdV-3. The hexon is a group-specific protein that induces formation of group-specific antibodies, making it an attractive diagnostic antigen and vaccine candidate. Expression of an N-terminal fragment of BAdV-3 hexon in E. coli yielded a 25-kDa recombinant protein that was recognized by MS/MS analysis with high confidence (Score 2033) [26]. More comprehensive work demonstrated that full-length recombinant hexon (rhexon) expressed in E. coli induced strong immune responses in both mice and goats, including long-term antibody production persisting for at least 16 weeks and significantly elevated levels of interferon-γ and interleukin-2 [4]. This suggests that rhexon preferentially induces a T helper 1 (Th1) cell response, which is critical for antiviral immunity. Despite these promising results, no commercial BAdV-3 vaccine has yet reached the market, highlighting the gap between preclinical success and commercial realization that persists in the veterinary vaccine field.

On the diagnostic front, advances in molecular detection have been equally impressive. A multiplex quantitative real-time PCR (qPCR) assay targeting six major BRDC pathogens, BRSV, BPIV3, BVDV, BAdV-3, Mycoplasma bovis, and IBRV, has been developed with impressive performance characteristics: detection limits ranging from 4.99 to 74.4 copies/μL, coefficients of variation below 4%, and amplification efficiencies between 93.84% and 111.60% [16]. Application of this assay to 224 naturally diseased cattle revealed a BAdV-3 detection rate of 22.32%, the second-highest among the six pathogens, with a mixed infection rate of 25%. This underscores the importance of BAdV-3 as a co-pathogen in BRDC and the value of multiplex platforms for comprehensive diagnosis. A nested PCR approach, using a common external primer pair and genus-specific internal primers targeting Mastadenovirus and Atadenovirus, has proven capable of detecting multiple BAdV subtypes (1, 3, 6, and 8) in field samples [13]. Antigen production has also been optimized, with cesium chloride gradient purification yielding three antigenic fractions from BAdV-1, the most purified of which contained a 50.0-kDa major region and induced antibody titers of 1:3200 in immunized rabbits [22].

Novel Antiviral Strategies

The emergence of cationic porphyrins as virucidal agents represents a novel approach to BAdV control. Free-base H2TMeP and ZnTMeP porphyrins demonstrate potent photoactivated virucidal activity against non-enveloped BAdV, achieving complete inactivation after 180 minutes of white-light exposure [42]. The mechanism involves the generation of reactive oxygen species (ROS) upon photoactivation, which then damage viral proteins and nucleic acids. This approach holds promise for decontaminating surfaces, biological substrates, and solutions in veterinary settings, particularly given the resistance of non-enveloped viruses to many conventional disinfectants.

Cell Culture Optimization and Virus Production

The successful exploitation of BAdVs for vaccine production depends critically on efficient cell culture systems. Optimization studies using the reference BAdV-1 strain “Adeno III WBR - 1” have demonstrated that the MDBK cell line, infected at a multiplicity of infection of 0.0001, is the most sensitive and productive system [39]. The maximum virus titer of (6.55 ± 0.21) log₁₀ TCID₅0/cm² was achieved using roller bottle cultivation at 24 hours post-infection, a significant improvement over stationary cultures. The BHK-21/13, Taurus-1, and KST cell lines also supported viral replication but with lower titers. These findings provide a practical framework for large-scale antigen and vaccine production.

In summary, the field of BAdV research has undergone a remarkable renaissance, driven by structural biology that

References

[1] Xiao H, Pang H, Zhou J, Feng H, Song J, Cheng L, et al.. Structural insights into minor and core proteins of bovine adenovirus 3: bridging capsid and genomic core.. Journal of Molecular Biology. 2025. DOI: https://doi.org/10.1016/j.jmb.2025.169208

[2] Werid G, Ibrahim YM, Girmay G, Hemmatzadeh F, Miller D, Kirkwood RN, et al.. Bovine adenovirus prevalence and its role in bovine respiratory disease complex: a systematic review and meta-analysis.. The Veterinary Journal. 2025. DOI: https://doi.org/10.1016/j.tvjl.2025.106303

[3] Li Q, He S, Zou Y, Yue H, Tang C, Liu J. Pathogenicity of a novel bovine adenovirus type 3 with a natural deletion partial fiber gene in BALB/c mice. Frontiers in Veterinary Science. 2023. DOI: https://doi.org/10.3389/fvets.2023.1138159

[4] Gundegmaa U, Raadan O, Wu H, Wang H, Wu M, Chu C. Recombinant Hexon Protein as a New Bovine Adenovirus Type 3 Subunit Vaccine Candidate. Journal of Veterinary Research. 2023. DOI: https://doi.org/10.2478/jvetres-2023-0014

[5] Jesse ST, Ciurkiewicz M, Siesenop U, Spitzbarth I, Osterhaus A, Baumgärtner W, et al.. Molecular characterization of a bovine adenovirus type 7 (Bovine Atadenovirus F) strain isolated from a systemically infected calf in Germany. Virology Journal. 2022. DOI: https://doi.org/10.1186/s12985-022-01817-y

[6] Vidovszky M, Böszörményi KP, Surján A, Varga T, Dán Á, Benkő M, et al.. First DNA sequence proof for the occurrence of bovine adenovirus types 10 and 11 in continental Europe.. Transboundary and Emerging Diseases. 2022. DOI: https://doi.org/10.1111/tbed.14752

[7] Kumagai A, Kajikawa S, Miyazaki A, Hatama S. Complete Genome Sequence of Bovine Adenovirus Type 7 Strain Fukuroi, Isolated from a Cow with Respiratory Disease. Microbiology Resource Announcements. 2021. DOI: https://doi.org/10.1128/MRA.00055-21

[8] Kumagai A, Kajikawa S, Miyazaki A, Hatama S. Whole-genome sequencing of live attenuated bovine adenovirus type 7 vaccine strain TS-GT suggests biomarkers for virulence attenuation. Journal of Veterinary Medical Science. 2021. DOI: https://doi.org/10.1292/jvms.22-0198

[9] Kubota N, Orihara S, Kumagai A, Kimura K, Hatama S. First Isolation, Molecular Characterization, and Serological Survey of Bovine Adenovirus Type 2 in Japan. . 2021. DOI: https://doi.org/10.21203/RS.3.RS-376772/V1

[10] Shen Y, Liu J, Zhang Y, Ma X, Yue H, Tang C. Prevalence and characteristics of a novel bovine adenovirus type 3 with a natural deletion fiber gene.. Infection, Genetics and Evolution. 2020. DOI: https://doi.org/10.1016/j.meegid.2020.104348

[11] Woldemariam T, Wang W, Said A, Tikoo S. Regions of bovine adenovirus-3 IVa2 involved in nuclear/nucleolar localization and interaction with pV.. Virology. 2020. DOI: https://doi.org/10.1016/j.virol.2020.04.006

[12] Sheet AA, Al-Baroodi S. Prevalence of the bovine adenovirus type 3 by using direct fluorescent antibody technique in calves in Nineveh province. Iraqi journal of Veterinary Sciences. 2020. DOI: https://doi.org/10.33899/ijvs.2019.125476.1009

[13] Shemel’kova GO, Yuzhakov A, Zaberezhny A, Shemel’kov EV, Aliper T. Development of a test system for detecting bovine adenovirus DNA based on polymerase chain reaction. IOP Conference Series: Earth and Environment. 2019. DOI: https://doi.org/10.1088/1755-1315/315/4/042027

[14] Gras C, Demoliner M, Eisen A, Spilki F, Henzel A. Seroprevalence of Bovine Adenovirus and Enterovirus Antibodies Reveals Different Infection Dynamics in Cattle Herds. Acta Scientiae Veterinariae. 2017. DOI: https://doi.org/10.22456/1679-9216.80212

[15] Nguyen TH, Vidovszky M, Ballmann M, Sanz‐Gaitero M, Singh AK, Harrach B, et al.. Crystal structure of the fibre head domain of bovine adenovirus 4, a ruminant atadenovirus. Virology Journal. 2015. DOI: https://doi.org/10.1186/s12985-015-0309-1

[16] Li L, Jiang Q, Li S, Li X, Sun S, Wang X, et al.. Establishment of a multiplex qPCR assay for the detection of pathogens associated with bovine respiratory disease complex. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1594488

[17] Zhu Y, Yu Z, Cai H, Gao Y, Dong X, Li Z, et al.. Isolation, identification, and complete genome sequence of a bovine adenovirus type 3 from cattle in China. Virology Journal. 2011. DOI: https://doi.org/10.1186/1743-422X-8-557

[18] Li X, Bangari D, Sharma A, Mittal S. Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry. Virology. 2009. DOI: https://doi.org/10.1016/j.virol.2009.06.029

[19] Mattson D. Naturally occurring infection of calves with a bovine adenovirus.. American Journal of Veterinary Research. 1973. DOI: https://doi.org/10.2460/ajvr.1973.34.05.623

[20] Na C, Dd D, Jm C, Dp H. Nitrogen metabolism of calves inoculated with bovine adenovirus-3 or with infectious bovine rhinotracheitis virus.. American Journal of Veterinary Research. 1986. DOI: https://doi.org/10.2460/ajvr.1986.47.05.1160

[21] Harrach B, Meehan B, Benkö M, Adair B, Todd D. Close phylogenetic relationship between egg drop syndrome virus, bovine adenovirus serotype 7, and ovine adenovirus strain 287.. Virology. 1997. DOI: https://doi.org/10.1006/VIRO.1996.8390

[22] Yarullin A, Mukhammadiev R, Mukhammadiev R, Karimullina IG, Sorokina D, Gumerov V. Development of a method for obtaining bovine adenovirus subgroup 1 antigen. Agrarian science. 2025. DOI: https://doi.org/10.32634/0869-8155-2025-399-10-17-24

[23] Kulanayake S, Dar F, Tikoo S. RETRACTED: Regions of Bovine Adenovirus-3 Protein VII Involved in Interactions with Viral and Cellular Proteins. Viruses. 2024. DOI: https://doi.org/10.3390/v16050732

[24] Kulanayake S, Singh B, Dar F, Tikoo S. RETRACTED: Role of Protein VII in the Production of Infectious Bovine Adenovirus-3 Virion. Viruses. 2024. DOI: https://doi.org/10.3390/v16081323

[25] Zhao X, Tikoo S. Nuclear and Nucleolar Localization of Bovine Adenovirus-3 Protein V. Frontiers in Microbiology. 2021. DOI: https://doi.org/10.3389/fmicb.2020.579593

[26] Mukantayev K, Tursunov K, Kanayev D, Tokhtarova L, Ramankulov Y, Mukanov K. OBTAINING STRAIN-PRODUCER OF RECOMBINANT HEXON OF BOVINE ADENOVIRUS TYPE 3. Eurasian journal of applied biotechnology. 2019. DOI: https://doi.org/10.11134/btp.1.2019.9

[27] Gaba A, Ayalew L, Patel AK, Kumar P, Tikoo S. Bovine adenovirus‐3 protein VIII associates with eukaryotic initiation factor‐6 during infection. Cellular Microbiology. 2018. DOI: https://doi.org/10.1111/cmi.12842

[28] Zhang P, Xue Q, Ma J, Ren J, Xia S, Zhang L, et al.. Bovine adenovirus type 3 virions cannot be rescued in vivo after full-length viral genome transfection in the absence of detectable polypeptide IX. Journal of Veterinary Sciences. 2017. DOI: https://doi.org/10.4142/jvs.2017.18.2.217

[29] Ayalew L, Patel AK, Gaba A, Islam A, Tikoo S. Bovine Adenovirus-3 pVIII Suppresses Cap-Dependent mRNA Translation Possibly by Interfering with the Recruitment of DDX3 and Translation Initiation Factors to the mRNA Cap. Frontiers in Microbiology. 2016. DOI: https://doi.org/10.3389/fmicb.2016.02119

[30] Kulshreshtha V, Islam A, Ayalew L, Tikoo S. Leucine residues in conserved region of 33K protein of bovine adenovirus - 3 are important for binding to major late promoter and activation of late gene expression.. Virology. 2015. DOI: https://doi.org/10.1016/j.virol.2015.04.010

[31] Kulshreshtha V, Ayalew L, Islam A, Tikoo S. Conserved Arginines of Bovine Adenovirus-3 33K Protein Are Important for Transportin-3 Mediated Transport and Virus Replication. PLoS ONE. 2014. DOI: https://doi.org/10.1371/journal.pone.0101216

[32] Ayalew L, Kumar P, Gaba A, Makadiya N, Tikoo S. Bovine adenovirus-3 as a vaccine delivery vehicle. Vaccine. 2014. DOI: https://doi.org/10.1016/j.vaccine.2014.11.055

[33] Kulanayake S, Dar F, Tikoo SK. RETRACTED: Kulanayake et al. Regions of Bovine Adenovirus-3 Protein VII Involved in Interactions with Viral and Cellular Proteins. Viruses 2024, 16, 732. Viruses. 2025. DOI: https://doi.org/10.3390/v17121605

[34] Kulanayake S, Singh B, Dar F, Tikoo SK. RETRACTED: Kulanayake et al. Role of Protein VII in the Production of Infectious Bovine Adenovirus-3 Virion. Viruses 2024, 16, 1323. Viruses. 2025. DOI: https://doi.org/10.3390/v17081133

[35] Anand S, Singh J, Gaba A, Tikoo S. Effect of bovine adenovirus 3 on mitochondria. Veterinary Research. 2014. DOI: https://doi.org/10.1186/1297-9716-45-45

[36] Stobnicka-Kupiec A, Gołofit-Szymczak M, Górny R, Cyprowski M. Prevalence of Bovine Leukemia Virus (BLV) and Bovine Adenovirus (BAdV) genomes among air and surface samples in dairy production. Journal of Occupational and Environmental Hygiene. 2020. DOI: https://doi.org/10.1080/15459624.2020.1742914

[37] Rc C, Aw M. Lesions and pathogenesis of disease in young calves experimentally induced by a bovine adenovirus type 5 isolated from a calf with weak calf syndrome.. American Journal of Veterinary Research. 1975. DOI: https://doi.org/10.2460/ajvr.1975.36.08.1095

[38] Aw M, Mf C. Infectivity of bovine adenovirus type 5 recovered from a polyarthritic calf with weak calf syndrome.. Journal of the American Veterinary Medical Association. 1975. DOI: https://doi.org/10.2460/javma.1975.167.02.139

[39] Mukhammadiev R, Yarullin A, Karimullina I, Galeeva A, Mukhammadiev R, Zaynullin L, et al.. Optimization of cultivation conditions for bovine adenovirus type 3. BIO Web of Conferences. 2025. DOI: https://doi.org/10.1051/bioconf/202517302010

[40] Chen T, Chu J, Song X, Yu Q, Deng G, Zeng J, et al.. Immunogenicity of a bivalent recombinant adenovirus expressing VP1 proteins of bovine norovirus and bovine nebovirus in mice and calves. BMC Microbiology. 2025. DOI: https://doi.org/10.1186/s12866-025-04542-y

[41] Zhang J, Wu J, Zhu Q, Huang X, Zhang Z, Zhu C, et al.. Protective efficacy of a recombinant adenovirus expressing novel dual F and HN proteins of bovine parainfluenza virus type 3. Veterinary Research. 2024. DOI: https://doi.org/10.1186/s13567-024-01400-z

[42] Ries A, Cargnelutti J, Basso G, Acunha TV, Iglesias B, Flores E, et al.. Water-soluble tetra-cationic porphyrins display virucidal activity against Bovine adenovirus and Bovine alphaherpesvirus 1.. Photodiagnosis and Photodynamic Therapy. 2020. DOI: https://doi.org/10.1016/j.pdpdt.2020.101947

[43] Baxi M, Deregt D, Robertson J, Babiuk LA, Schlapp T, Tikoo SK. Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats.. Virology. 2000. DOI: https://doi.org/10.1006/VIRO.2000.0661

[44] Said A, Wang W, Woldermariam T, Tikoo S. Domains of bovine adenovirus-3 protein 22K involved in interacting with viral protein 52K and cellular importins α-5/α-7.. Virology. 2018. DOI: https://doi.org/10.1016/j.virol.2018.07.015

[45] Ren J, Zhang L, Cheng P, Zhang F, Liu Z, Tikoo S, et al.. Generation of infectious clone of bovine adenovirus type I expressing a visible marker gene.. Journal of Virological Methods. 2018. DOI: https://doi.org/10.1016/j.jviromet.2018.08.020